Myelomas
A Multicenter, Phase 1b, Open-label Study to Evaluate Dose Optimization Measures and Safety of ABBV-383 in Subjects with Relapsed or Refractory Multiple Myeloma (M24-108)
- Details
ClinicalTrials.gov ID:
NCT05650632
Diagnosis Type:
NA
USOR Number:
- Address
,
P: